EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diabetes and Sarcopenia: Unraveling the Metabolic Crossroads of Muscle Loss and Glycemic Dysregulation

Jose Jorge Ortez Toro

Endocrines · 18.09.2025 · 6 (3) · 47

DOI: 10.3390/endocrines6030047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrines, online erschienen am 18.09.2025. Verfasst von Jose Jorge Ortez Toro. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intersection of type 2 diabetes mellitus (T2DM) and sarcopenia, often termed diabetic sarcopenia, represents a critical yet underrecognized comorbidity that significantly impacts the quality of life and functional capacity of older adults. This paper explores the complex interplay between T2DM and sarcopenia, focusing on the prevalence, risk factors, and underlying mechanisms driving muscle mass and strength decline in this population. Drawing from recent clinical studies, we highlight a prevalence of sarcopenia ranging from 15.36% to 30.2% among elderly T2DM patients, with notable gender disparities (41.3% in men versus 20.1% in women) and regional variations. Key risk factors identified include poor glycemic control (HbA1c ≥8%), longer diabetes duration (>5 years), low body mass index (BMI), and reduced levels of 25-hydroxyvitamin D and insulin-like growth factor-1 (IGF-1). We also recommend a practical screening algorithm for diabetic sarcopenia, integrating tools like the SARC-F questionnaire, dynamometry, and BMI-adjusted calf circumference to facilitate early diagnosis and staging in clinical settings. The review underscores the need for a multidisciplinary approach—encompassing pharmacological optimization, nutritional interventions with high-protein diets, and tailored physical exercise—to mitigate muscle loss and improve metabolic outcomes. Future research directions should focus on validating diagnostic protocols and diagnosis techniques and further exploring specific therapies to effectively address this dual burden.

Zitieren

APA

Toro, J. J. O. (2025). Diabetes and Sarcopenia: Unraveling the Metabolic Crossroads of Muscle Loss and Glycemic Dysregulation. Endocrines, 6(3), 47. https://doi.org/10.3390/endocrines6030047

Vancouver

Toro JJO. Diabetes and Sarcopenia: Unraveling the Metabolic Crossroads of Muscle Loss and Glycemic Dysregulation. Endocrines. 2025;6(3):47. doi:10.3390/endocrines6030047

BibTeX
@article{Toro2025,
  author = {Toro, Jose Jorge Ortez},
  title = {Diabetes and Sarcopenia: Unraveling the Metabolic Crossroads of Muscle Loss and Glycemic Dysregulation},
  journal = {Endocrines},
  year = {2025},
  volume = {6},
  number = {3},
  pages = {47},
  doi = {10.3390/endocrines6030047}
}
Kostenlos starten →